Probiotec Limited (AU:PBP) has released an update.
Probiotec Limited has announced the court-approved dispatch of a supplementary scheme booklet related to its acquisition by PYFA Australia Pty Ltd, a subsidiary of PT Pyridam Farma TBK. Shareholders are advised to review the booklet for information on the updated debt funding arrangements prior to the scheme meeting for voting. The Independent Expert has endorsed the acquisition as fair and reasonable, recommending shareholder approval in the absence of a better proposal.
For further insights into AU:PBP stock, check out TipRanks’ Stock Analysis page.
